A. M. A. Arafat, S. K. A. Botros, R. Afifi, S. A. Zayed, and M. Fateen, “Serum Level of High-Mobility Group Box Protein 1 as a Potential Treatment Target in Egyptian Sickle Cell Disease Patients”, Open Access Maced J Med Sci, vol. 10, no. B, pp. 1072–1078, Apr. 2022.